{"id":8537,"date":"2026-11-16T17:53:14","date_gmt":"2026-11-16T16:53:14","guid":{"rendered":"https:\/\/oncopeptides.com\/investors\/aktien\/nyemissioner\/nyemission-oktober-2026\/"},"modified":"2026-11-16T18:04:34","modified_gmt":"2026-11-16T17:04:34","slug":"nyemission-oktober-2026","status":"publish","type":"investors","link":"https:\/\/oncopeptides.com\/sv\/investerare\/aktien\/nyemissioner\/nyemission-oktober-2026\/","title":{"rendered":"Nyemission oktober 2026"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"8537\" class=\"elementor elementor-8537 elementor-8531\" data-elementor-post-type=\"investors\">\n\t\t\t\t<style>\n                .elementor-element-5e03ac1{\n                --padding-top: var(--webien-padding-top-none);\n                --padding-right: var(--webien-padding-right-none);\n                --padding-bottom: var(--webien-padding-bottom-none);\n                --padding-left: var(--webien-padding-left-none);\n                }\n            <\/style><div class=\"webien-container-padding-none elementor-element elementor-element-5e03ac1 e-flex e-con-boxed e-con e-parent\" data-id=\"5e03ac1\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<style>\n                .elementor-element-5f610b7{\n                --padding-top: var(--webien-padding-top-none);\n                --padding-right: var(--webien-padding-right-none);\n                --padding-bottom: var(--webien-padding-bottom-none);\n                --padding-left: var(--webien-padding-left-none);\n                }\n            <\/style><div class=\"webien-container-padding-none elementor-element elementor-element-5f610b7 e-con-full haus-2-1 e-flex e-con e-child\" data-id=\"5f610b7\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-f4baaef elementor-widget elementor-widget-heading\" data-id=\"f4baaef\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h1 class=\"elementor-heading-title elementor-size-default\">Nyemission<br \/><span style=\"color: var(--color-orange)\">oktober 2026<\/span><\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-cf49e9a dotted-divider elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"cf49e9a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t<style>\n                .elementor-element-5c3a561{\n                --padding-top: var(--webien-padding-top-none);\n                --padding-right: var(--webien-padding-right-none);\n                --padding-bottom: var(--webien-padding-bottom-none);\n                --padding-left: var(--webien-padding-left-none);\n                }\n            <\/style><div class=\"webien-container-padding-none elementor-element elementor-element-5c3a561 e-con-full e-flex e-con e-child\" data-id=\"5c3a561\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-409e18e elementor-widget elementor-widget-text-editor\" data-id=\"409e18e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h2>Oncopeptides har genomf\u00f6rt en riktad nyemission om cirka 100 MSEK<\/h2>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d92303e elementor-widget elementor-widget-text-editor\" data-id=\"d92303e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t13 oktober 2026 \u2013 Regulatoriskt pressmeddelande\n\nStyrelsen f\u00f6r Oncopeptides AB (publ) (\u201dOncopeptides\u201d eller \u201dBolaget\u201d) (Nasdaq Stockholm: ONCO), ett biotechbolag inriktat p\u00e5 sv\u00e5rbehandlade cancersjukdomar, har beslutat att emittera 50 000 000 nya stamaktier (de \u201dNya Aktierna\u201d) i en riktad nyemission till svenska och internationella institutionella investerare, med st\u00f6d av bemyndigandet fr\u00e5n \u00e5rsst\u00e4mman den 21 maj 2026 (den \u201dRiktade Nyemissionen\u201d). Teckningskursen har fastst\u00e4llts till 2,00 SEK per Ny Aktie och den Riktade Nyemissionen tillf\u00f6r Bolaget en likvid om 100 MSEK f\u00f6re avdrag f\u00f6r transaktionskostnader.\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-87903b8 elementor-widget elementor-widget-button\" data-id=\"87903b8\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t\t\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/oncopeptides.com\/sv\/pressmeddelanden\/oncopeptides-har-genomfort-en-riktad-nyemission-om-cirka-100-msek\/\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">L\u00e4s pressmeddelandet<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-13f7252 dotted-divider elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"13f7252\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<style>\n                .elementor-element-de96ca1{\n                --padding-top: var(--webien-padding-top-none);\n                --padding-right: var(--webien-padding-right-none);\n                --padding-bottom: var(--webien-padding-bottom-none);\n                --padding-left: var(--webien-padding-left-none);\n                }\n            <\/style><div class=\"webien-container-padding-none elementor-element elementor-element-de96ca1 e-con-full e-flex e-con e-child\" data-id=\"de96ca1\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-a9b298f elementor-widget elementor-widget-text-editor\" data-id=\"a9b298f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h2>Oncopeptides avser att genomf\u00f6ra en riktad nyemission om cirka 100 MSEK<\/h2>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-b4c62fe elementor-widget elementor-widget-text-editor\" data-id=\"b4c62fe\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t13 oktober 2026 \u2013 Regulatoriskt pressmeddelande\n\nOncopeptides AB (publ) (\u201dOncopeptides\u201d eller \u201dBolaget\u201d) (Nasdaq Stockholm: ONCO), ett biotechbolag inriktat p\u00e5 sv\u00e5rbehandlade cancersjukdomar, meddelar idag sin avsikt att genomf\u00f6ra en riktad nyemission av aktier om cirka 100 MSEK till svenska och internationella institutionella investerare genom ett accelererat bookbuilding-f\u00f6rfarande (den \u201dRiktade Nyemissionen\u201d). Bolaget avser att anv\u00e4nda nettolikviden till att genomf\u00f6ra de CMC-aktiviteter som kr\u00e4vs inf\u00f6r n\u00e4sta kliniska utvecklingsfas, slutf\u00f6ra f\u00f6rberedelserna inf\u00f6r klinisk studiestart och finansiera genomf\u00f6randet av denna fas inom Bolagets glioblastomprogram. Den Riktade Nyemissionen syftar till att uppr\u00e4tth\u00e5lla utvecklingstakten och m\u00f6jligg\u00f6ra f\u00f6r programmet att n\u00e5 en viktig klinisk milstolpe.\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-937e7e7 elementor-widget elementor-widget-button\" data-id=\"937e7e7\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t\t\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/oncopeptides.com\/sv\/pressmeddelanden\/oncopeptides-avser-att-genomfora-en-riktad-nyemission-om-cirka-100-msek\/\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">L\u00e4s pressmeddelandet<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c4d680f dotted-divider elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"c4d680f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"featured_media":0,"parent":5698,"menu_order":0,"template":"","meta":{"_acf_changed":false},"protected-content":[341],"class_list":["post-8537","investors","type-investors","status-publish","hentry","protected-content-show-disclaimer"],"acf":[],"_links":{"self":[{"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/investors\/8537","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/investors"}],"about":[{"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/types\/investors"}],"version-history":[{"count":1,"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/investors\/8537\/revisions"}],"predecessor-version":[{"id":8538,"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/investors\/8537\/revisions\/8538"}],"up":[{"embeddable":true,"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/investors\/5698"}],"wp:attachment":[{"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/media?parent=8537"}],"wp:term":[{"taxonomy":"protected-content","embeddable":true,"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/protected-content?post=8537"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}